Proassurance CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
ProAssurance Corporation reported a net income of $8.46 million for Q1 2026, a significant improvement from a net loss in the prior year, despite a 5.4% decrease in net premiums earned.
NYSE
ProAssurance Corporation reported a significant decline in net income and earnings per share for the third quarter and first nine months of 2025, primarily due to increased transaction-related costs for its pending merger with The Doctors Company and higher loss ratios.
NYSE
ProAssurance Corporation reported a decrease in net income for the second quarter and first half of 2025, driven by merger-related costs and investment losses, despite favorable loss reserve development and improved underwriting ratios.
NYSE
ProAssurance Corporation's Q1 2025 results reveal a net loss, impacted by transaction-related costs and foreign exchange losses, while the company progresses with its merger agreement with The Doctors Company.
NYSE
ProAssurance Corporation's Q3 2024 results show a complex picture with improved underwriting in some areas offset by challenges in others, alongside strategic adjustments in its investment portfolio.
NYSE
ProAssurance Corporation's second quarter results show a mixed performance with a decrease in net premiums earned but an increase in net investment income.
NYSE
ProAssurance Corporation's first quarter of 2024 saw a return to profitability, though results were mixed across segments and impacted by market conditions and prior year adjustments.